Make a donation Start a fundraiser
  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us
  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us
Dylan King

Dylan King

Current Development of Monoclonal Antibodies in Cancer Therapy.

[…]

Read More… from Current Development of Monoclonal Antibodies in Cancer Therapy.

Global conformational changes in IgG-Fc upon mutation of the FcRn-binding site are not associated with altered antibody-dependent effector functions.

[…]

Read More… from Global conformational changes in IgG-Fc upon mutation of the FcRn-binding site are not associated with altered antibody-dependent effector functions.

Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptor.

[…]

Read More… from Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptor.

Glyceride lipid formulations: molecular dynamics modeling of phase behavior during dispersion and molecular interactions between drugs and excipients.

[…]

Read More… from Glyceride lipid formulations: molecular dynamics modeling of phase behavior during dispersion and molecular interactions between drugs and excipients.

Using molecular dynamics to study liquid phase behavior: simulations of the ternary sodium laurate/sodium oleate/water system.

[…]

Read More… from Using molecular dynamics to study liquid phase behavior: simulations of the ternary sodium laurate/sodium oleate/water system.

Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion

[…]

Read More… from Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion

Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion

[…]

Read More… from Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion

  • Our Story
    • Our Story
    • Fiona Elsey’s Dream
    • Governance
      • Board of Directors
      • Donor Reports
      • Terms & Policies
    • Community Partners
    • Supporter Stories
    • News & Media
  • Research
    • Our Research
    • Research Projects
      • Ovarian Cancer
      • Immunology
      • Chronic Lymphocytic Leukemia (CLL)
      • Langerhans Cell Histocytosis
      • Bowel cancer
      • Breast cancer
      • Renal cancer
    • Research Team
    • Collaborations
    • Publications
  • Get Involved
    • Get Involved
    • Donate
    • Fundraise for Research
    • Bendigo Telco
    • Leave a Gift in Your Will
    • Workplace Giving
    • Volunteer
    • Grain For Hope appeal
  • Events
    • Upcoming Events
  • Contact Us

Fundraisers

News & media

  • Irene’s memory to make a difference to research.
  • Creswick Community Bank
  • Skin cell breakthrough could lead to new treatments.
  • New finding from Breast cancer group.

Contact

admin@fecri.org.au



Phone

03 5331 3101

Location

Ballarat Technology Park
- Central Suite 23,
106-110 Lydiard St Sth
Ballarat Vic 3350

Postal

PO Box 549,
Ballarat VIC 3350

All material © Fiona Elsey Cancer Research Institute.

Site by
Pepper Brandmanagers